Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting

© 2020 The Author(s) Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in children worldwide and is a significant cause of hospital admissions in young children in England. No RSV vaccine has been licensed but a number are under development. In this work, we prese...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy Kinyanjui, Wirichada Pan-Ngum, Sompob Saralamba, Sylvia Taylor, Lisa White, D. James Nokes
Other Authors: GlaxoSmithKline Pharmaceuticals SA/NV
Format: Article
Published: 2020
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/53561
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University